| Target Price | $38.25 |
| Price | $31.95 |
| Potential | 19.72% |
| Number of Estimates | 21 |
| 21 Analysts have issued a price target Keurig Dr Pepper Inc 2027 . The average Keurig Dr Pepper Inc target price is $38.25. This is 19.72% higher than the current stock price. The highest price target is $44.10 38.03% , the lowest is $29.29 8.33% . | |
| A rating was issued by 24 analysts: 16 Analysts recommend Keurig Dr Pepper Inc to buy, 8 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Keurig Dr Pepper Inc stock has an average upside potential 2027 of 19.72% . Most analysts recommend the Keurig Dr Pepper Inc stock at Purchase. |
22 Analysts have issued a sales forecast Keurig Dr Pepper Inc 2026 . The average Keurig Dr Pepper Inc sales estimate is
This results in the following potential growth metrics:
18 Analysts have issued an Keurig Dr Pepper Inc EBITDA forecast 2026. The average Keurig Dr Pepper Inc EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
23 Keurig Dr Pepper Inc Analysts have issued a net profit forecast 2026. The average Keurig Dr Pepper Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
23 Analysts have issued a Keurig Dr Pepper Inc forecast for earnings per share. The average Keurig Dr Pepper Inc EPS is
This results in the following potential growth metrics and future valuations:
Keurig Dr Pepper Inc...
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Argus Research |
Buy
➜
Buy
|
Unchanged | Sep 15 2026 |
| HSBC |
Hold
➜
Buy
|
Upgrade | Aug 13 2026 |
| Barclays |
Overweight
➜
Overweight
|
Unchanged | Aug 10 2026 |
| Evercore ISI Group |
In-Line
➜
In-Line
|
Unchanged | Aug 07 2026 |
| UBS |
Buy
➜
Buy
|
Unchanged | Aug 07 2026 |
| JP Morgan |
Overweight
➜
Overweight
|
Unchanged | Jul 23 2026 |
| UBS |
Buy
➜
Buy
|
Unchanged | Jul 16 2026 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
Argus Research:
Buy
➜
Buy
|
Sep 15 2026 |
|
Upgrade
HSBC:
Hold
➜
Buy
|
Aug 13 2026 |
|
Unchanged
Barclays:
Overweight
➜
Overweight
|
Aug 10 2026 |
|
Unchanged
Evercore ISI Group:
In-Line
➜
In-Line
|
Aug 07 2026 |
|
Unchanged
UBS:
Buy
➜
Buy
|
Aug 07 2026 |
|
Unchanged
JP Morgan:
Overweight
➜
Overweight
|
Jul 23 2026 |
|
Unchanged
UBS:
Buy
➜
Buy
|
Jul 16 2026 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


